SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: finbar who wrote (1471)4/7/2007 6:27:05 AM
From: paolo gorgo  Respond to of 1475
 
unfortunately, I believe the milestone is due when completing a phase 2 trial - so still quite a long way, unless they speed up the trial or Medimmune decides to buy out BTRNQ rights on siplizumab...